A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a business.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Regulators voted in new rules aimed at protecting investors considering investing in the nontraditional setup.
Though small compared to each company’s total workforces, work stoppages have set uncomfortable precedents for management.
This month marks the end of what Goldman Sachs estimates will be a record year for stock buybacks, with a volume of roughly $930 billion.
In the first 11 months of the year, 1,991 CEOs have announced their departures, up 16% compared to the same timeframe last year.